Patent Assignment
Reel/Frame 040645/0282
Assignment of Assignor's Interest
Recorded: 2016-11-17
Pages: 32
Assignor
CATALYST BIOSCIENCES, INC.
Executed: 2016-10-14
Assignee
OYSTER POINT PHARMA, INC.
395 OYSTER POINT BLVD., SUITE 501, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property
(1)
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3-Ylvinyl)Pyrimidine
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Nov 17, 2016
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 040645/0359 →
Assignment of Assignor's Interest
Nov 17, 2016
From: AKIREDDY, SRINIVASA RAO; BHATTI, BALWINDER SINGH; CUTHBERTSON, TIMOTHY J.; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 040364/0118 →
Change of Name
Jan 13, 2017
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 041044/0211 →
Assignment of Assignor's Interest
Jan 13, 2017
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 041043/0769 →
Patent Security Agreement
Aug 5, 2021
From: OYSTER POINT PHARMA, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057104/0189 →
Corrective Assignment to Correct the the Conveying Party Execution Date Previously Recorded at Reel: 041044 Frame: 0211. Assignor(S) Hereby Confirms the Assignment.
Oct 26, 2021
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 057923/0518 →
Release of Security Interest
Feb 3, 2023
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: OYSTER POINT PHARMA INC.
Reel/Frame 062582/0873 →